EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Levodopa and Dopamine Agonists in Neovascular Age-Related Macular Degeneration in the Sight Outcomes Research Collaborative Database

Kyle S Chan, Harrshavasan T S Congivaram, Andrea S Cuamatzi-Castelan, Jeremy A Lavine, SOURCE Consortium

Ophthalmology Retina · 2026-04 · 10 (4) · 353-361

DOI: 10.1016/j.oret.2025.12.004 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2026-04. Verfasst von Kyle S Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Hauptthemen laut MEDLINE: Levodopa, Dopamine Agonists, Wet Macular Degeneration, Visual Acuity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, Research to Prevent Blindness, Illinois Society for the Prevention of Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaDopamine AgonistsWet Macular DegenerationVisual AcuityHumansRetrospective StudiesMaleFemaleAgedDatabases, FactualFollow-Up StudiesAged, 80 and overMiddle AgedDisease Progression

Stichwörter der Autor:innen

Age-related macular degenerationDopamineDopamine receptor D2LevodopaSight Outcomes Research Collaborative

Substanzen

LevodopaDopamine Agonists

Autor:innen und Institutionen

  • Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: jeremy.lavine@northwestern.edu.

Förderung

  • NEI NIH HHS
  • Research to Prevent Blindness
  • Illinois Society for the Prevention of Blindness
  • National Eye Institute

Zitieren

APA

Chan, K. S., Congivaram, H. T. S., Cuamatzi-Castelan, A. S., Lavine, J. A., & SOURCE Consortium (2026). Levodopa and Dopamine Agonists in Neovascular Age-Related Macular Degeneration in the Sight Outcomes Research Collaborative Database. Ophthalmology Retina, 10(4), 353-361. https://doi.org/10.1016/j.oret.2025.12.004

Vancouver

Chan KS, Congivaram HTS, Cuamatzi-Castelan AS, Lavine JA, SOURCE Consortium. Levodopa and Dopamine Agonists in Neovascular Age-Related Macular Degeneration in the Sight Outcomes Research Collaborative Database. Ophthalmology Retina. 2026;10(4):353-361. doi:10.1016/j.oret.2025.12.004

BibTeX
@article{Chan2026,
  author = {Chan, Kyle S and Congivaram, Harrshavasan T S and Cuamatzi-Castelan, Andrea S and Lavine, Jeremy A and SOURCE Consortium, SOURCE Consortium},
  title = {Levodopa and Dopamine Agonists in Neovascular Age-Related Macular Degeneration in the Sight Outcomes Research Collaborative Database},
  journal = {Ophthalmology Retina},
  year = {2026},
  volume = {10},
  number = {4},
  pages = {353--361},
  doi = {10.1016/j.oret.2025.12.004}
}
Kostenlos starten →